Clinical Trial Update: Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update reports safety and efficacy findings for FURESTEM-RA Inj. in patients with moderate to severe rheumatoid arthritis across Phase 1 and Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• FURESTEM-RA Inj. (unknown)

Snippet

Sponsor: Kang Stem Biotech Co., Ltd. | Conditions: Rheumatoid Arthritis | Phase 1, Phase 2 | Status: COMPLETED